Capture 20d e2 80 99e cc 81cran 202022 01 06 20a cc 80 2014.04.43
Ipeps v1 rvb

Janssen Digital Solutions QuickFire Challenge

Nov 20 - Jul 20 | Paris, France
The Brain and Spine institute innovation accelerator

About this Program

Driven by a desire to prevent disease, Janssen Pharmaceutica NV, powered by Johnson & Johnson Innovation, together with the Paris Brain Institute (ICM) ; is launching the Janssen Digital Solutions QuickFire Challenge, inviting EMEA-based companies[1] to submit technologies and solutions with the potential to scale for impact across EMEA within the next five years.

The five innovator(s) with the most promising ideas will receive residency at the iPEPS incubator for nine months - inclusive of support that aims to help health tech startups accelerate their growth and reach scale across EMEA - as well as mentoring and coaching from Janssen[2] with access to commercial expertise and connections. Finalists will also receive pitch coaching from Johnson & Johnson Innovation with the chance to pitch live at this year’s AI4health Virtual Conference.

Wherever you are in EMEA, you will be able to take full advantage of this programme as it will be held entirely digitally.

Here are some tips for submitting your application:
- Please answer all questions English only.
- Please try to keep your answers short and straight to the point
- Make your application the most exhaustive you can, incomplete application will not be considered

If you need any assistance, or have any question, feel free to write us at:

[1] Start-ups registered in the form of companies, whose domain is Digital or Medtech
2 Mentoring carried out by local Janssen collaborators in each European country with the aim to support startups in their development by providing general medical/pharma expertise and access to KOLs and players in the healthcare sector. EMEA includes countries in Europe, Middle East & Africa Region. JANSSEN reserves the right to limit or restrict participation by any person, at any time, for any reason, including, but not limited to, due to U.S. government sanctions and restrictions on transactions or other activities with certain countries, individuals and entities as stated in the Terms and Conditions of this QFC.


Biotechnology, Healthcare Services, Medical Devices and Equipment